E1	Or:T4 Arg:T2 Arg2:T3
E2	Eq-Comparison:T5 Temporal-Unit:T7 Value:T6 Operator:T8
E3	Age:T9 Eq-Comparison:E2
E4	Observation:T10 Name:T11
E5	Observation:T12 Name:T13 Eq-Comparison:E8
E6	Study:T14
E7	Temporal-Connection:T15 Arg:E6 Arg2:E4
E8	Eq-Comparison:T16 Operator:T17 Value:T18 Per:T19
E9	Eq-Comparison:T20 Operator:T21 Value:T22 Per:T23
E10	Or:T24 Arg:E8 Arg2:E9
E11	Immunization:T25 Name:T26 Temporality:E12 Temporality2:E74
E12	Eq-Comparison:T27 Temporal-Unit:T30 Operator:T28 Value:T29
E13	Study:T31
E14	Temporal-Connection:T32 Arg:E12 Arg2:E13
E15	Observation:T33 Name:T34
E16	Observation:T35 Name:T36 Eq-Comparison:E17
E17	Eq-Comparison:T37 Operator:T38 Value:T39 Unit:T40 Per:T41
E18	Eq-Comparison:T42 Operator:T43 Value:T44 Unit:T45 Per:T46
E19	Or:T47 Arg:E17 Arg2:E18
E20	Study:T48
E21	Temporal-Connection:T49 Arg:E16 Arg2:E20
E22	Condition:T50 Name:T51 Acuteness:T52
E25	Or:T54 Arg2:T52 Arg:T53
E26	Condition:T55 Name:T56
E27	Condition:T57 Name:T58
E28	Condition:T59 Name:T60
E29	Condition:T61 Name:T62
E30	Condition:T63 Name:T64
E31	Modifier:T65 Modifies:T64
E32	Modifier:T66 Modifies:T64
E33	Or:T67 Arg:E32 Arg2:E31
E34	Condition:T68 Name:T69
E35	Condition:T70 Name:T71
E36	Condition:T72 Name:T73
E37	Condition:T74 Name:T75
E38	Or:T76 Arg:E36 Arg2:E37
E39	Drug:T77 Name:T78 Temporality:E42
E40	Drug:T79 Name:T80
E41	Or:T81 Arg:E39 Arg2:E40
E42	Eq-Comparison:T82 Temporal-Period:T83
E43	Condition:T84 Name:T85 Temporality:E45 Stability:T144
E44	Study:T86
E45	Eq-Comparison:T87 Operator:T88 Temporal-Unit:T90 Value:T89
E46	Temporal-Connection:T91 Arg:E45 Arg2:E44
E47	Drug:T92 Name:T93 Temporality:E49 Temporality2:E75
E48	Study:T94
E49	Eq-Comparison:T95 Temporal-Unit:T98 Operator:T96 Value:T97
E50	Temporal-Connection:T99 Arg:E49 Arg2:E48
E51	Condition:T100 Name:T101
E52	Assertion:T102 Asserted:E51
E53	Modifier:T103 Modifies:T101
E54	Modifier:T104 Modifies:T101
E55	Or:T105 Arg:E53 Arg2:E54
E56	Observation:T106 Name:T107 Temporality:E58
E57	Study:T108
E58	Eq-Comparison:T109 Temporal-Unit:T112 Operator:T110 Value:T111
E59	Temporal-Connection:T113 Arg:E58 Arg2:E57
E60	Observation:T114 Name:T115
E61	Observation:T116 Name:T117 Eq-Comparison:E64
E62	Observation:T118 Name:T119
E63	Observation:T120 Name:T121 Eq-Comparison:E64
E64	Eq-Comparison:T122 Operator:T123 Unit:T125 Value:T124
E65	Observation:T126 Name:T127
E66	Eq-Comparison:T128 Value:T130 Operator:T129 Unit2:T131 Per:T132
E67	Condition:T133 Name:T134
E68	Condition:T135 Name:T136
E69	Or:T137 Arg:E67 Arg2:E68
E70	Condition:T138 Name:T139
E71	Drug:T141 Name:T142
E72	Assertion:T143 Asserted:E73
E73	Negation:T145 Negates:E71
E74	Eq-Comparison:T146 Temporal-Period:T147
E75	Eq-Comparison:T148 Temporal-Period:T149
T1	Life-Stage-And-Gender 25 30	Adult
T2	Life-Stage-And-Gender 31 34	men
T3	Life-Stage-And-Gender 39 44	women
T4	Or 35 38	and
T5	Eq-Comparison 45 58	over 50 years
T6	Eq-Value 50 52	50
T7	Eq-Temporal-Unit 53 58	years
T8	Eq-Operator 45 49	over
T9	Age 53 58	years
T10	Observation 266 282	white blood cell
T11	Observation-Name 266 282	white blood cell
T12	Observation 283 286	WBC
T13	Observation-Name 283 286	WBC
T14	Study 241 250	screening
T15	Temporal-Connection 251 256	shows
T16	Eq-Comparison 291 307	less than 3000/㎕
T17	Eq-Operator 291 300	less than
T18	Eq-Value 301 305	3000
T19	Eq-Unit 306 307	㎕
T20	Eq-Comparison 311 327	more than 8000/㎕
T21	Eq-Operator 311 320	more than
T22	Eq-Value 321 325	8000
T23	Eq-Unit 326 327	㎕
T24	Or 308 310	or
T25	Immunization 352 373	influenza vaccination
T26	Immunization-Name 352 373	influenza vaccination
T27	Eq-Comparison 374 389	within 3 months
T28	Eq-Operator 374 380	within
T29	Eq-Value 381 382	3
T30	Eq-Temporal-Unit 383 389	months
T31	Study 401 410	screening
T32	Temporal-Connection 390 396	before
T33	Observation 433 448	body mass index
T34	Observation-Name 433 448	body mass index
T35	Observation 449 452	BMI
T36	Observation-Name 449 452	BMI
T37	Eq-Comparison 457 479	less than 18.5 kg / m2
T38	Eq-Operator 457 466	less than
T39	Eq-Value 467 471	18.5
T40	Eq-Unit 472 474	kg
T41	Eq-Unit 477 479	m2
T42	Eq-Comparison 483 506	greater than 35 kg / m2
T43	Eq-Operator 483 495	greater than
T44	Eq-Value 496 498	35
T45	Eq-Unit 499 501	kg
T46	Eq-Unit 504 506	m2
T47	Or 480 482	or
T48	Study 514 523	screening
T49	Temporal-Connection 507 509	at
T50	Condition 586 607	cardiovascular system
T51	Condition-Name 586 607	cardiovascular system
T52	Acuteness 578 585	chronic
T54	Or 575 577	or
T55	Condition 609 625	endocrine system
T56	Condition-Name 609 625	endocrine system
T57	Condition 627 640	immune system
T58	Condition-Name 627 640	immune system
T59	Condition 642 660	respiratory system
T60	Condition-Name 642 660	respiratory system
T61	Condition 662 682	liver biliary system
T62	Condition-Name 662 682	liver biliary system
T63	Condition 703 709	system
T64	Condition-Name 703 709	system
T65	Modifier 695 702	urinary
T66	Modifier 684 690	kidney
T67	Or 691 694	and
T68	Condition 711 726	neuropsychiatry
T69	Condition-Name 711 726	neuropsychiatry
T70	Condition 728 750	musculoskeletal system
T71	Condition-Name 728 750	musculoskeletal system
T72	Condition 752 764	inflammatory
T73	Condition-Name 752 764	inflammatory
T74	Condition 769 780	hematologic
T75	Condition-Name 769 780	hematologic
T76	Or 765 768	and
T77	Drug 803 813	medication
T78	Drug-Name 803 813	medication
T79	Drug 817 837	health function food
T80	Drug-Name 817 837	health function food
T81	Or 814 816	or
T82	Eq-Comparison 796 800	take
T83	Eq-Temporal-Period 796 800	take
T84	Condition 856 877	promotion of immunity
T85	Condition-Name 856 877	promotion of immunity
T86	Study 906 915	screening
T87	Eq-Comparison 878 892	within 1 month
T88	Eq-Operator 878 884	within
T89	Eq-Value 885 886	1
T90	Eq-Temporal-Unit 887 892	month
T91	Temporal-Connection 893 898	prior
T92	Drug 945 969	antipsychotic medication
T93	Drug-Name 945 969	antipsychotic medication
T94	Study 993 1002	screening
T95	Eq-Comparison 970 985	within 3 months
T96	Eq-Operator 970 976	within
T97	Eq-Value 977 978	3
T98	Eq-Temporal-Unit 979 985	months
T99	Temporal-Connection 986 992	before
T100	Condition 1036 1041	abuse
T101	Condition-Name 1036 1041	abuse
T102	Assertion 1042 1051	suspected
T103	Modifier 1018 1027	alcoholic
T104	Modifier 1031 1035	drug
T105	Or 1028 1030	or
T106	Observation 1067 1104	participated in other clinical trials
T107	Observation-Name 1067 1104	participated in other clinical trials
T108	Study 1128 1137	screening
T109	Eq-Comparison 1105 1120	within 3 months
T110	Eq-Operator 1105 1111	within
T111	Eq-Value 1112 1113	3
T112	Eq-Temporal-Unit 1114 1120	months
T113	Temporal-Connection 1121 1127	before
T114	Observation 1199 1221	Aspartate Transaminase
T115	Observation-Name 1199 1221	Aspartate Transaminase
T116	Observation 1222 1225	AST
T117	Observation-Name 1222 1225	AST
T118	Observation 1228 1248	Alanine Transaminase
T119	Observation-Name 1228 1248	Alanine Transaminase
T120	Observation 1249 1252	ALT
T121	Observation-Name 1249 1252	ALT
T122	Eq-Comparison 1254 1291	> Reference range 3 times upper limit
T123	Eq-Operator 1254 1255	>
T124	Eq-Value 1272 1273	3
T125	Eq-Unit 1280 1291	upper limit
T126	Observation 1302 1318	Serum Creatinine
T127	Observation-Name 1302 1318	Serum Creatinine
T128	Eq-Comparison 1319 1330	> 2.0 mg/dL
T129	Eq-Operator 1319 1320	>
T130	Eq-Value 1321 1324	2.0
T131	Eq-Unit 1325 1327	mg
T132	Eq-Unit 1328 1330	dL
T133	Condition 1336 1345	Pregnancy
T134	Condition-Name 1336 1345	Pregnancy
T135	Condition 1349 1363	breast feeding
T136	Condition-Name 1349 1363	breast feeding
T137	Or 1346 1348	or
T138	Condition 1447 1459	childbearing
T139	Condition-Name 1447 1459	childbearing
T140	Life-Stage-And-Gender 1460 1465	woman
T141	Drug 1428 1441	contraception
T142	Drug-Name 1428 1441	contraception
T143	Assertion 1387 1393	accept
T144	Stability 843 850	affects
T145	Negation 1379 1386	doesn't
T146	Eq-Comparison 343 351	received
T147	Eq-Temporal-Period 343 351	received
T148	Eq-Comparison 936 944	received
T149	Eq-Temporal-Period 936 944	received
T53	Acuteness 569 574	acute
A1	Life-Stage-And-Gender-Type T1 adult
A2	Life-Stage-And-Gender-Type T2 male
A3	Life-Stage-And-Gender-Type T3 female
A4	Eq-Temporal-Unit-Value T7 year
A5	Eq-Operator-Value T8 GT
A6	Observation-Type-Value T11 lab
A7	Observation-Type-Value T13 lab
A8	Temporal-Connection-Type-Value E7 during
A9	Eq-Operator-Value T17 LT
A10	Eq-Operator-Value T21 GT
A11	Eq-Operator-Value T28 LTEQ
A12	Eq-Temporal-Unit-Value T30 month
A13	Temporal-Connection-Type-Value E14 before
A14	Observation-Type-Value T34 vital
A15	Observation-Type-Value T36 vital
A16	Eq-Operator-Value T38 LT
A17	Eq-Operator-Value T43 GT
A18	Temporal-Connection-Type-Value E21 during
A19	Eq-Temporal-Period-Value T83 present
A20	Eq-Operator-Value T88 LTEQ
A21	Eq-Temporal-Unit-Value T90 month
A22	Temporal-Connection-Type-Value E46 before
A23	Eq-Operator-Value T96 LTEQ
A24	Eq-Temporal-Unit-Value T98 month
A25	Temporal-Connection-Type-Value E50 before
A26	Assertion-Type-Value E52 possible
A27	Eq-Operator-Value T110 LTEQ
A28	Eq-Temporal-Unit-Value T112 month
A29	Temporal-Connection-Type-Value E59 before
A30	Observation-Type-Value T115 lab
A31	Observation-Type-Value T117 lab
A32	Observation-Type-Value T119 lab
A33	Observation-Type-Value T121 lab
A34	Eq-Operator-Value T123 GT
A35	Eq-Unit-Value T125 ref-range-high
A36	Observation-Type-Value T127 lab
A37	Eq-Operator-Value T129 GT
A38	Life-Stage-And-Gender-Type T140 female
A39	Assertion-Type-Value E72 hypothetical
A40	Stability-Value T144 change
A41	Eq-Temporal-Period-Value T147 past
A42	Eq-Temporal-Period-Value T149 past
A44	Acuteness-Type-Value T53 acute
A45	Acuteness-Type-Value T52 chronic
R1	Abbrev-Of Arg1:E5 Arg2:E4
R2	Abbrev-Of Arg1:E16 Arg2:E15
R4	Abbrev-Of Arg1:E61 Arg2:E60
R5	Abbrev-Of Arg1:E63 Arg2:E62
R6	If-Then Arg1:T140 Arg2:E70
R7	Treatment-For Arg1:E71 Arg2:E70
R3	Caused-By Arg1:T144 Arg2:E40